EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Nanoparticle-Based Treatment Approaches for Skin Cancer: A Systematic Review

Michael Joseph Diaz, Nicole Natarelli iD, Shaliz Aflatooni, Sarah J Aleman, Sphurti Neelam, Jasmine Thuy Tran, Kamil Taneja, Brandon Lucke-Wold iD, Mahtab Forouzandeh

Current Oncology · 25.07.2023 · 30 (8) · 7112-7131

DOI: 10.3390/curroncol30080516 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Current Oncology, online erschienen am 25.07.2023. Verfasst von Michael Joseph Diaz und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, University of Florida, Gainesville, FL 32610, USA. Hauptthemen laut MEDLINE: Skin Neoplasms, Nanoparticles. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanoparticles have shown marked promise as both antineoplastic agents and drug carriers. Despite strides made in immunomodulation, low success rates and toxicity remain limitations within the clinical oncology setting. In the present review, we assess advances in drug delivery nanoparticles, for systemic and topical use, in skin cancer treatment. A systematic review of controlled trials, meta-analyses, and Cochrane review articles was conducted. Eligibility criteria included: (1) a primary focus on nanoparticle utility for skin cancer; (2) available metrics on prevention and treatment outcomes; (3) detailed subject population; (4) English language; (5) archived as full-text journal articles. A total of 43 articles were selected for review. Qualitative analysis revealed that nanoscale systems demonstrate significant antineoplastic and anti-metastasis properties: increased drug bioavailability, reduced toxicity, enhanced permeability and retention effect, as well as tumor growth inhibition, among others. Nanoformulations for skin cancers have largely lagged behind those tested in other cancers–several of which have commercialized formulae. However, emerging evidence has indicated a powerful role for these carriers in targeting primary and metastatic skin cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsNanoparticlesHumans

Stichwörter der Autor:innen

drug carriersinorganicnanoparticleorganicskin cancersystematic review

Autor:innen und Institutionen

  • College of Medicine, University of Florida, Gainesville, FL 32610, USA.
  • Morsani College of Medicine, University of South Florida, Tampa, FL 33602, USA.
  • School of Medicine, Louisiana State University, New Orleans, LA 70112, USA.
  • School of Medicine, Indiana University, Indianapolis, IN 46202, USA.
  • Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA.
  • Department of Neurosurgery, University of Florida, Gainesville, FL 32608, USA.

ORCID-Profile: Nicole Natarelli, Brandon Lucke-Wold

Zitieren

APA

Diaz, M. J., Natarelli, N., Aflatooni, S., Aleman, S. J., Neelam, S., Tran, J. T., Taneja, K., Lucke-Wold, B., & Forouzandeh, M. (2023). Nanoparticle-Based Treatment Approaches for Skin Cancer: A Systematic Review. Current Oncology, 30(8), 7112-7131. https://doi.org/10.3390/curroncol30080516

Vancouver

Diaz MJ, Natarelli N, Aflatooni S, Aleman SJ, Neelam S, Tran JT, et al. Nanoparticle-Based Treatment Approaches for Skin Cancer: A Systematic Review. Current Oncology. 2023;30(8):7112-7131. doi:10.3390/curroncol30080516

BibTeX
@article{Diaz2023,
  author = {Diaz, Michael Joseph and Natarelli, Nicole and Aflatooni, Shaliz and Aleman, Sarah J and Neelam, Sphurti and Tran, Jasmine Thuy and Taneja, Kamil and Lucke-Wold, Brandon and Forouzandeh, Mahtab},
  title = {Nanoparticle-Based Treatment Approaches for Skin Cancer: A Systematic Review},
  journal = {Current Oncology},
  year = {2023},
  volume = {30},
  number = {8},
  pages = {7112--7131},
  doi = {10.3390/curroncol30080516}
}
Kostenlos starten →